Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan M Fogelman

Showing results (21-30 of 149) with videos related to

Pageof 15
Sort By:
Circulation|October 7, 2004
Genetic basis of atherosclerosis: part II: clinical implicationsAldons J Lusis, Alan M Fogelman, Gregg C Fonarow
Current Atherosclerosis Reports|August 12, 2006
High-density lipoprotein: is it always atheroprotective?Benjamin J Ansell, Gregg C Fonarow, Alan M Fogelman
Current Atherosclerosis Reports|December 16, 2006
Modifying the anti-inflammatory effects of high-density lipoproteinBenjamin J Ansell, Gregg C Fonarow, Mohamad Navab, et al.
Current Opinion in Lipidology|July 1, 2014
Apolipoprotein A-I mimeticsSrinivasa T Reddy, Mohamad Navab, Gattadahalli M Anantharamaiah, et al.
Nature Clinical Practice. Cardiovascular Medicine|September 23, 2006
Apolipoprotein A-I mimetic peptides and their role in atherosclerosis preventionMohamad Navab, G M Anantharamaiah, Srinivasa T Reddy, et al.
Circulation Research|January 4, 2014
High-density lipoprotein: vascular protective effects, dysfunction, and potential as therapeutic targetThomas F Lüscher, Ulf Landmesser, Arnold von Eckardstein, et al.
Biochimica Et Biophysica Acta|January 28, 2014
Searching for a successful HDL-based treatment strategySrinivasa T Reddy, Mohamad Navab, G M Anantharamaiah, et al.
Nature Reviews. Cardiology|February 10, 2011
HDL and cardiovascular disease: atherogenic and atheroprotective mechanismsMohamad Navab, Srinivasa T Reddy, Brian J Van Lenten, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 9, 2004
Apparent paradox of low-fat "healthy" diets increasing plasma levels of oxidized low-density lipoprotein and lipoprotein(a)Mohamad Navab, Srinivasa T Reddy, Brian J Van Lenten, et al.
Journal of Lipid Research|July 20, 2004
PLTP deficiency improves the anti-inflammatory properties of HDL and reduces the ability of LDL to induce monocyte chemotactic activityDaoguang Yan, Mohamad Navab, Can Bruce, et al.
Pageof 15

Showing results (21-30 of 149) with videos related to

Sort By:
Pageof 15
Circulation|October 7, 2004
Genetic basis of atherosclerosis: part II: clinical implicationsAldons J Lusis, Alan M Fogelman, Gregg C Fonarow
Current Atherosclerosis Reports|August 12, 2006
High-density lipoprotein: is it always atheroprotective?Benjamin J Ansell, Gregg C Fonarow, Alan M Fogelman
Current Atherosclerosis Reports|December 16, 2006
Modifying the anti-inflammatory effects of high-density lipoproteinBenjamin J Ansell, Gregg C Fonarow, Mohamad Navab, et al.
Current Opinion in Lipidology|July 1, 2014
Apolipoprotein A-I mimeticsSrinivasa T Reddy, Mohamad Navab, Gattadahalli M Anantharamaiah, et al.
Nature Clinical Practice. Cardiovascular Medicine|September 23, 2006
Apolipoprotein A-I mimetic peptides and their role in atherosclerosis preventionMohamad Navab, G M Anantharamaiah, Srinivasa T Reddy, et al.
Circulation Research|January 4, 2014
High-density lipoprotein: vascular protective effects, dysfunction, and potential as therapeutic targetThomas F Lüscher, Ulf Landmesser, Arnold von Eckardstein, et al.
Biochimica Et Biophysica Acta|January 28, 2014
Searching for a successful HDL-based treatment strategySrinivasa T Reddy, Mohamad Navab, G M Anantharamaiah, et al.
Nature Reviews. Cardiology|February 10, 2011
HDL and cardiovascular disease: atherogenic and atheroprotective mechanismsMohamad Navab, Srinivasa T Reddy, Brian J Van Lenten, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 9, 2004
Apparent paradox of low-fat "healthy" diets increasing plasma levels of oxidized low-density lipoprotein and lipoprotein(a)Mohamad Navab, Srinivasa T Reddy, Brian J Van Lenten, et al.
Journal of Lipid Research|July 20, 2004
PLTP deficiency improves the anti-inflammatory properties of HDL and reduces the ability of LDL to induce monocyte chemotactic activityDaoguang Yan, Mohamad Navab, Can Bruce, et al.
Pageof 15